Cargando…

Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III

Dengue virus (DENV) is a mosquito-borne disease caused by four genetically and serologically related viruses termed DENV-1, -2, -3 and -4. The DENV envelope (E) protein ectodomain can be divided into three structural domains designated ED1, ED2 and ED3. The ED3 domain contains DENV type-specific and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsui, Kiyohiko, Gromowski, Gregory D., Li, Li, Barrett, Alan D. T.
Formato:	Texto
Lenguaje:	English
Publicado:	Society for General Microbiology 2010
Materias:	Animal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052520/ https://www.ncbi.nlm.nih.gov/pubmed/20444995 http://dx.doi.org/10.1099/vir.0.021220-0

Ejemplares similares

Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III
por: Ji, Guang-Hui, et al.
Publicado: (2015)

Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus
por: Chaudhury, Sidhartha, et al.
Publicado: (2017)

Diagnostic Performance of Dengue Virus Envelope Domain III in Acute Dengue Infection
por: Nguyen, Ngoc Minh, et al.
Publicado: (2019)

Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient
por: Aaskov, John, et al.
Publicado: (2007)

Dengue virus type-3 envelope protein domain III; expression and immunogenicity
por: Fahimi, Hossein, et al.
Publicado: (2014)

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus
por: Swanstrom, J. A., et al.
Publicado: (2016)

Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies
por: Kudlacek, Stephan T., et al.
Publicado: (2021)

Epitope Presentation of Dengue Viral Envelope Glycoprotein Domain III on Hepatitis B Core Protein Virus-Like Particles Produced in Nicotiana benthamiana
por: Pang, Ee Leen, et al.
Publicado: (2019)

Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
por: Zhu, Deanna R., et al.
Publicado: (2023)

Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein
por: Maeda, Denicar Lina Nascimento Fabris, et al.
Publicado: (2017)

Molecular Changes in Dengue Envelope Protein Domain III upon Interaction with Glycosaminoglycans
por: Hyatt, James G., et al.
Publicado: (2020)

Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
por: Park, Jisang, et al.
Publicado: (2020)

Immunogenic Subviral Particles Displaying Domain III of Dengue 2 Envelope Protein Vectored by Measles Virus
por: Harahap-Carrillo, Indira S., et al.
Publicado: (2015)

In silico binding analysis of lutein and rosmarinic acid against envelope domain III protein of dengue virus
por: Panchal, Ritesh, et al.
Publicado: (2021)

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III
por: Hu, Dan, et al.
Publicado: (2019)

Alanine Substitution Inactivates Cross-Reacting Epitopes in Dengue Virus Recombinant Envelope Proteins
por: Zomosa-Signoret, Viviana C., et al.
Publicado: (2020)

Characterization and epitope mapping of Dengue virus type 1 specific monoclonal antibodies
por: Chen, Wen-Hung, et al.
Publicado: (2017)

DNA Vaccines against Dengue Virus Type 2 Based on Truncate Envelope Protein or Its Domain III
por: Azevedo, Adriana S., et al.
Publicado: (2011)

Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris
por: Kaushik, Neha, et al.
Publicado: (2016)

Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
por: Metz, Stefan W., et al.
Publicado: (2018)

Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses
por: Pereira, Samuel Santos, et al.
Publicado: (2023)

Production of dengue 2 envelope domain III in plant using CPMV - based vector system
por: Carlos Marques, Lívia Érika, et al.
Publicado: (2014)

Immunogenicity of a novel tetravalent dengue envelope protein domain III-based antigen in mice
por: Fahimi, Hossein, et al.
Publicado: (2018)

Characterization of epitope-tagged foot-and-mouth disease virus
por: Seago, Julian, et al.
Publicado: (2012)

Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
por: Arora, Upasana, et al.
Publicado: (2012)

Dengue Virus Envelope Protein Domain III Induces Nlrp3 Inflammasome-Dependent NETosis-Mediated Inflammation in Mice
por: Lien, Te-Sheng, et al.
Publicado: (2021)

Hijacking the Host Immune Cells by Dengue Virus: Molecular Interplay of Receptors and Dengue Virus Envelope
por: Begum, Feroza, et al.
Publicado: (2019)

Transcriptional response of Wolbachia-transinfected Aedes aegypti mosquito cells to dengue virus at early stages of infection
por: Leitner, Michael, et al.
Publicado: (2022)

Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein
por: Tang, Chung-Tao, et al.
Publicado: (2015)

Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
por: Rouvinski, Alexander, et al.
Publicado: (2017)

Computational Analysis of Dengue Virus Envelope Protein (E) Reveals an Epitope with Flavivirus Immunodiagnostic Potential in Peptide Microarrays
por: Bergamaschi, Greta, et al.
Publicado: (2019)

Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody
por: Keelapang, Poonsook, et al.
Publicado: (2023)

Viperin is anti-viral in vitro but is dispensable for restricting dengue virus replication or induction of innate and inflammatory responses in vivo
por: Al Shujairi, Wisam-Hamzah, et al.
Publicado: (2021)

Dendritic Cell Targeting Using a DNA Vaccine Induces Specific Antibodies and CD4(+) T Cells to the Dengue Virus Envelope Protein Domain III
por: Zaneti, Arthur Baruel, et al.
Publicado: (2019)

Computational prediction and identification of dengue virus-specific CD4(+) T-cell epitopes
por: Wen, Jin-Sheng, et al.
Publicado: (2008)

Comparison of Neutralizing Dengue Virus B Cell Epitopes and Protective T Cell Epitopes With Those in Three Main Dengue Virus Vaccines
por: Pinheiro, Josilene Ramos, et al.
Publicado: (2021)

Identification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3)
por: da Silva, Andréa N. M. Rangel, et al.
Publicado: (2009)

A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies
por: Chua, Anthony JS, et al.
Publicado: (2013)

In silico analysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate
por: Fahimi, Hossein, et al.
Publicado: (2016)

Expression of an immunocomplex consisting of Fc fragment fused with a consensus dengue envelope domain III in Saccharomyces cerevisiae
por: So, Kum-Kang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jbl21rqistj3s2b1197adg9cl6